Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 27 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

33%

9 trials in Phase 3/4

Results Transparency

12%

2 of 17 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (9)
P 1 (2)
P 2 (3)
P 3 (2)
P 4 (7)

Trial Status

Completed17
Not Yet Recruiting3
Unknown3
Recruiting2
Active Not Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT07479615Phase 3Not Yet Recruiting

A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis

NCT07438509Phase 4Not Yet Recruiting

Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema

NCT06787586Phase 1Active Not Recruiting

Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

NCT07228962Not Yet Recruiting

Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies

NCT05590585Phase 4Completed

Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

NCT07205081Phase 1Recruiting

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

NCT03409367Not ApplicableCompleted

A Community-based Assessment of Skin Care, Allergies, and Eczema

NCT06230991Not ApplicableActive Not RecruitingPrimary

A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema

NCT06453512Not ApplicableRecruitingPrimary

A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema

NCT05454722Not ApplicableCompletedPrimary

A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.

NCT03143504UnknownPrimary

A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study

NCT04114097Phase 4Completed

The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover

NCT02915146Not ApplicableCompletedPrimary

Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema

NCT02300701Phase 4CompletedPrimary

Role of Anti-IgE in Severe Childhood Eczema

NCT01854580Completed

Evaluation of an Integrated Care Project

NCT03270566Not ApplicableUnknownPrimary

Softened Water for Eczema Prevention Pilot Trial

NCT00555178Completed

Regulatory T Cells (Tregs) in Polymorphic Light Eruption

NCT00826592Not ApplicableCompleted

Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis

NCT02381028Not ApplicableCompletedPrimary

Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children

NCT01179529Phase 2Completed

Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage

Scroll to load more

Research Network

Activity Timeline